Esmail, Mosrif A.

HRN: 22-74-04  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/20/2024
CEFUROXIME 750MG (VIAL)
12/20/2024
12/27/2024
IV
400 Mg
Q 8 Hours
BFC; URTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: